Cemiplimab-Associated Eruption of Generalized Eruptive Keratoacanthoma of Grzybowski

Cutis. 2024 Jan;113(1):E8-E10. doi: 10.12788/cutis.0935.

Authors

Bianca Y Kang¹, Raveena Khanna¹, Meera H Patel¹, David J Glembocki¹, Brooke G Jeffy¹, Maya K Thosani¹, Neel B Patel¹

Affiliation

¹ Drs. Kang, Khanna, M.H. Patel, and N.B. Patel are from Creighton University School of Medicine, Phoenix Regional Campus, Arizona. Drs. Glembocki and N.B. Patel are from Southwest Skin Specialists, Phoenix. Drs. Jeffy and Thosani are from Spectrum Dermatology, Phoenix.

PMID: 38478940
DOI: 10.12788/cutis.0935

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Exanthema*
Humans
Keratoacanthoma* / chemically induced
Keratoacanthoma* / diagnosis

Substances

cemiplimab
Antibodies, Monoclonal, Humanized